State Key Laboratory of Diagnosis and Treatment of Infectious Diseases

Recent papers from State Key Laboratory of Diagnosis and Treatment of Infectious Diseases

1. Four-year longitudinal multicenter susceptibility trends of aztreonam–avibactam and ceftazidime–avibactam and dose optimization in critically ill patient populations against carbapenem-resistant Enterobacterales bloodstream infectionsEngineering Microbiology · 2026
2. Dietary patterns and odds of prevalent gout comorbidity in diabetes mellitus: a mediation analysis of glucose metabolism and renal functionJournal of Global Health · 2026
3. Comparative performance evaluation of two rapid molecular assays for detecting drug-resistant tuberculosis in clinical isolatesMicrobiology Spectrum · 2026
4. WTAP resists cholestatic liver injury by m 6 A-IGF2BP1-dependent regulation of the nuclear receptor FXRGut · 2026
5. Proteomic signatures of cardiovascular imaging phenotypes and links with cardiovascular and systemic outcomes: a prospective cohort and Mendelian randomization studyCardiovascular Diabetology · 2026
6. Global Underutilization of Antiviral Therapy and Survival Outcomes in Hepatitis B Virus‐Related Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis of 78 Studies and 68,243 PatientsJournal of Viral Hepatitis · 2026
7. Breast Cancer Stem Cell-Associated Extracellular Vesicles: Bioengineering Advances in Source-Resolved Isolation, Mechanistic Validation, and Clinical TranslationBioengineering · 2026
8. Targeting receptor tyrosine kinases: from molecular mechanisms to clinical therapeuticsSignal Transduction and Targeted Therapy · 2026
9. Unveiling mechanisms and potential application of probiotics in chronic inflammation and agingJournal of Functional Foods · 2026
10. Noninvasive diagnosis of Alzheimer’s disease: a review of emerging biomarkers and multimodal approachesFrontiers in Cell and Developmental Biology · 2026
11. Immune Checkpoint Inhibitor–Based Downstaging Therapy for Hepatocellular CarcinomaJAMA Oncology · 2026
12. Stem cell–based approaches in hepatitis B virus–related liver disease: therapeutic potential and advances in human-derived research modelsStem Cell Research & Therapy · 2026
13. Application of artificial intelligence in hepatologyFrontiers in Digital Health · 2026
14. Gastric bacterial microbiota and gastric carcinogenesis: from dysbiosis to immune remodeling and therapeutic opportunitiesFrontiers in Immunology · 2026
15. STING signaling in liver diseases and the therapeutic potential of nanodrug delivery systemsGenes & Diseases · 2026
16. PI3K/AKT signaling pathway: molecular crossroads in tumorigenesis and therapeutic innovationSignal Transduction and Targeted Therapy · 2026
17. HBV re-activation is associated with increased mortality and dysregulation of oxidative and polyamine metabolism in pre-acute-on-chronic liver failureCell Communication and Signaling · 2026
18. Functional mapping of IFITM3 resolves its antiviral core and deciphers human influenza susceptibilityCommunications Biology · 2026
19. Social license for vaccination: a mixed-methods analysis of public endorsement determinantsHumanities and Social Sciences Communications · 2026
20. Multiomics Analysis Identifies Microbiota, Immune and Metabolomics Changes Across Disease Stages of COVID-19: A Retrospective StudyInfectious Microbes & Diseases · 2026